Mike Y. Osei‐Atweneboana

Author

Council for Scientific and Industrial Research ORCID

Also Known As

M. OSEI‐ATWENEBOANA, M. Y. Osei-Atweneboana, M. Y. Osei‐Atweneboana, M.Y. Osei-Atweneboana, MIKE Y. OSEI-ATWENEBOANA, Mike Osei-Atweneboana, Mike Y Osei-Atweneboana, Mike Y. Osei-Atweneboana, Mike Y. Osei‐Atweneboana, Mike Yaw Osei-Atweneboana

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Council for Scientific and Industrial Research University of Ghana Noguchi Memorial Institute for Medical Research Liverpool School of Tropical Medicine Ghana Health Service

About

Mike Y. Osei‐Atweneboana is an author at Council for Scientific and Industrial Research specializing in medicine, parasitology, and pathogenesis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.1K
2	Natural Sciences	2	2	62
3	Public Health	2	2	244
4	Health Sciences	1	1	59
5	Allergy	1	1	224

Mike Y. Osei‐Atweneboana

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study Mike Y. Osei‐Atweneboana, J.K.L. Eng, Daniel A. Boakye, The Lancet Soil-transmitted HelminthiasisDisease TransmissionInfection ControlHelminth InfectionMedicine	2007	376
Phenotypic Evidence of Emerging Ivermectin Resistance in Onchocerca volvulus Mike Y. Osei‐Atweneboana, Kwablah Awadzi, Simon K. Attah, PLoS neglected tropical diseases	2011	301
An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana K. Awadzi, Daniel A. Boakye, G. Edwards, Annals of Tropical Medicine and Parasitology Parasitic DiseaseAntiparasitic AgentPathologyOnchocerciasis-endemic FociClinical Mycology	2004	224
Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity Stephen R. Doyle, Catherine Bourguinat, Hugues C. Nana-Djeunga, PLoS neglected tropical diseases	2017	223
Identifying sub-optimal responses to ivermectin in the treatment of River Blindness Thomas S. Churcher, Sébastien D. S. Pion, Mike Y. Osei‐Atweneboana, Proceedings of the National Academy of Sciences Ocular DiseaseIvermectin ResistanceDermatologyDrug ResistanceRiver Blindness	2009	210
Does Increasing Treatment Frequency Address Suboptimal Responses to Ivermectin for the Control and Elimination of River Blindness? Kwadwo K. Frempong, Martin Walker, Robert Cheke, Clinical Infectious Diseases	2016	195
The Cost of Annual versus Biannual Community-Directed Treatment of Onchocerciasis with Ivermectin: Ghana as a Case Study Hugo C. Turner, Mike Y. Osei‐Atweneboana, Martin Walker, PLoS neglected tropical diseases	2013	184
Ivermectin selection on β-tubulin: Evidence in Onchocerca volvulus and Haemonchus contortus J.K.L. Eng, William J. Blackhall, Mike Y. Osei‐Atweneboana, Molecular and Biochemical Parasitology BiologyIvermectin SelectionOnchocerca VolvulusPhysiologyPathogenesis	2006	97
Reaching the London Declaration on Neglected Tropical Diseases Goals for Onchocerciasis: An Economic Evaluation of Increasing the Frequency of Ivermectin Treatment in Africa Hugo C. Turner, Martin Walker, Thomas S. Churcher, Clinical Infectious Diseases	2014	92
Doxycycline Leads to Sterility and Enhanced Killing of Female<i>Onchocerca volvulus</i>Worms in an Area With Persistent Microfilaridermia After Repeated Ivermectin Treatment: A Randomized, Placebo-Controlled, Double-Blind Trial Alexander Yaw Debrah, Sabine Specht, Ute Klarmann‐Schulz, Clinical Infectious Diseases	2015	76

Page 1